Debra L Monticciolo1, Mark A Helvie2, R Edward Hendrick3. 1. 1 Department of Radiology, Scott & White Medical Center, Texas A&M University Health Sciences, 2401 S 31st St, MS-01-W256, Temple, TX 76508. 2. 2 Department of Radiology and Comprehensive Cancer Center, Michigan Medicine, University of Michigan, Ann Arbor, MI. 3. 3 Department of Radiology, University of Colorado School of Medicine, Aurora, CO.
Abstract
OBJECTIVE: The discovery of breast cancer at earlier stages with screening brings the risk that some cancers will be overdiagnosed or overtreated. Reasonable estimates show the overdiagnosis rate due to screening mammography to be low, 1-10%. CONCLUSION: Overdiagnosis should not be used as a reason to delay the onset or decrease the frequency of screening, because neither strategy will decrease overdiagnosis. Improvements in personalized treatment will diminish the morbidity of treatment and, therefore, the significance of overdiagnosis.
OBJECTIVE: The discovery of breast cancer at earlier stages with screening brings the risk that some cancers will be overdiagnosed or overtreated. Reasonable estimates show the overdiagnosis rate due to screening mammography to be low, 1-10%. CONCLUSION: Overdiagnosis should not be used as a reason to delay the onset or decrease the frequency of screening, because neither strategy will decrease overdiagnosis. Improvements in personalized treatment will diminish the morbidity of treatment and, therefore, the significance of overdiagnosis.
Entities:
Keywords:
breast cancer; breast cancer diagnosis; overdiagnosis; overtreatment; screening mammography
Authors: José Revilla-López; Andrea Anampa-Guzmán; Luis Casanova Marquez; Katrina Weeks; Suzanne Pollard; Adriel Olórtegui-Yzú; María Ruiz-Velazco; Alba Davila-Edquen; Daniel Castro-Dorer; Juan Wong-Barrenechea; Jossira Abad-Seminario; Pamela Gonzáles-Ramos; Fiorella Rivera-Sandoval; Carlos Carracedo-Gonzáles Journal: Infect Agent Cancer Date: 2019-11-29 Impact factor: 2.965